Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease.
Meden, A., Knez, D., Jukic, M., Brazzolotto, X., Grsic, M., Pislar, A., Zahirovic, A., Kos, J., Nachon, F., Svete, J., Gobec, S., Groselj, U.(2019) Chem Commun (Camb) 55: 3765-3768
- PubMed: 30864579 
- DOI: 10.1039/c9cc01330j
- Primary Citation of Related Structures:  
6QAA, 6QAB, 6QAC, 6QAD, 6QAE - PubMed Abstract: 
We have identified tryptophan-based selective nanomolar butyrylcholinesterase (BChE) inhibitors. They are defined according to their chemical modularity, novel binding mode revealed by five solved crystal structures with human BChE, low cytotoxicity, and predicted permeability of the blood-brain barrier ...